Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001203779 | SCV001374956 | likely benign | Peutz-Jeghers syndrome | 2022-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002375133 | SCV002688482 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-03-28 | criteria provided, single submitter | clinical testing | The c.863-3_863-2dupCA intronic variant, results from a duplication of CA four nucleotides upstream from coding exon 7 of the STK11 gene. These nucleotide positions are highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |